Abstract
Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of oral paltusotine, a small-molecule, selective somatostatin receptor subtype 2 agonist
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have